Table 3.

Summary of breakthrough inflammation after surgery with an intravitreal injection of triamcinolone–moxifloxacin–vancomycin

Breakthrough inflammation (n = 1429a)
Cases with breakthrough inflammation at Days 14–21 [n (%)]	132 (9.2)
Concomitant conditions (cases with inflammation/total eyes)
Diabetes	41/448
Glaucoma	11/57b
Ethnicity and race (cases with inflammation/total eyes)
Nonwhite	40/347
Medications prescribed
Total	147c
Corticosteroid	72
Nonsteroidal anti-inflammatory drug	75

^aA total of 112 cases did not return for a follow-up at Days 14–21.

^bStatistically significantly different from the proportion of cases without the corresponding concomitant condition in the overall case set (n = 1429), chi-squared test.

^cSome cases received more than one medication, so the number of medications differs from the number of cases that received medication.